COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,221 Articles (22,733 medRxiv, 8,488 bioRxiv)

Most recent first Previous |  Page 238: Articles 2371-2380  | Next

IDRWalker: A Random Walk based Modeling Tool for Disordered Regions in Proteins
Chen, G., Zhang, Z.
10.1101/2024.03.17.585378 — Posted: 2024-03-18
Binding of SARS-CoV-2 nucleocapsid protein to uninfected epithelial cells induces antibody-mediated complement deposition
Fahoum, J., Billan, M., Varga, J. K., Padawer, D., Elgrably-Weiss, M., Basu, P., Stolovich-Rain, M., Baraz, L., Kumari, S., Oiknine-Dijan, E., Kumar, M., Cohen-Kfir, E., Zelig, O., Mayer, G., Isupov, M. N., Wolf, D. G., Altuvia, S., Wiener, R., Schueler-Furman, O., Rouvinski, A.
10.1101/2024.03.17.585388 — Posted: 2024-03-18
CORACLE (COVID-19 liteRAture CompiLEr): A platform for efficient tracking and extraction of SARS-CoV-2 and COVID-19 literature, with examples from post-COVID with respiratory involvement
Piontkovskaya, K., Luo, Y., Lindberg, P., Gao, J., Runold, M., Kolosenko, I., Li, C.-X., Wheelock, A. M.
10.1101/2024.03.18.584627 — Posted: 2024-03-18
Atomically accurate de novo design of single-domain antibodies
Bennett, N. R., Watson, J. L., Ragotte, R. J., Borst, A. J., See, D. L., Weidle, C., Biswas, R., Shrock, E. L., Leung, P. J. Y., Huang, B., Goreshnik, I., Ault, R., Carr, K. D., Singer, B., Criswell, C., Vafeados, D., Garcia Sanchez, M., Kim, H. M., Vazquez Torres, S., Chan, S., Baker, D.
10.1101/2024.03.14.585103 — Posted: 2024-03-18
Interventions for the management of post COVID-19 condition (long COVID): Protocol for a living systematic review & network meta-analysis
Zeraatkar, D., Ling, M., Kirsh, S., Jassal, T., Pitre, T., Chakraborty, S., Turner, T., Turkstra, L., McIntyre, R. S., Izcovich, A., Mbuagbaw, L., Agoritsas, T., Flottorp, S., Garner, P., Couban, R., Busse, J.
10.1101/2024.03.15.24304168 — Posted: 2024-03-16
The extent and impact of vaccine status miscategorisation on covid-19 vaccine efficacy studies
Neil, M., McLachlan, S., Fenton, N.
10.1101/2024.03.09.24304015 — Posted: 2024-03-16
Comparative safety and effectiveness of Pfizer BA.4-5 versus Sanofi during the spring 2023 COVID-19 booster vaccination programme in England: a matched cohort study in OpenSAFELY-TPP
The OpenSAFELY Collaborative, , Andrews, C. D., Prestige, E., Parker, E. P. K., Walker, V., Palmer, T., Schaffer, A. L., Green, A. C., Curtis, H. J., Walker, A. J., Smith, R. M., Wood, C., Bates, C., Mehrkar, A., MacKenna, B., Bacon, S. C., Goldacre, B., Hernan, M. A., Sterne, J. A., Hulme, W. J.
10.1101/2024.03.15.24304277 — Posted: 2024-03-16
Frequency of Depressive Symptoms and Suicidal Ideation Among University Students Before and After the COVID-19 Pandemic
Macalli, M., Castel, L., Jacqmin-gadda, H., Tournier, M., Galera, C., Pereira, E., Tzourio, C.
10.1101/2024.03.14.24304160 — Posted: 2024-03-16
ONE HEALTH APPROACH ON SARS-COV-2 - USING SHEEP AS SENTINEL ANIMALS TO INCREASE FUTURE PANDEMIC PREPAREDNESS - a pilot study
Samojlovic, M., Mesquita, J., Santos-Silva, S., Neptin, M., Esbjornsson, J.
10.1101/2024.03.15.585163 — Posted: 2024-03-15
Substantial reduction in the clinical and economic burden of disease following variant-adapted mRNA COVID-19 vaccines in immunocompromised patients in France
Lee, A., Davido, B., Beck, E., Demont, C., Joshi, K., Kohli, M., Maschio, M., Uhart, M., El Mouaddin, N.
10.1101/2024.03.13.24304170 — Posted: 2024-03-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).